CareRx (CRRX) investor relations material

Market opportunity and demand

• One in five Canadians are aged 65 or older, with seniors consuming about 40% of prescription drugs and 25% of OTC drugs.

• Over 500,000 congregate care beds exist in Canada, forecasted to double in 15 years as the over-65 population grows by 1.5 million by 2031.

• Spending on senior care is projected to rise from $29.9 billion in 2021 to $58.5 billion by 2031.

• Ontario plans to build 58,000 new or upgraded long-term care beds by 2028.

Business model and service offering

• Specializes in pharmacy services for seniors housing communities, focusing on high-touch, same-day delivery and complex medication management.

• Operates a purpose-built model distinct from retail pharmacy, tailored for long-term care (LTC) residents.

• Delivers integrated clinical, operational, and distribution solutions, promoting efficiency and strong partnerships with LTC operators.

• Maintains stable, long-term contracts (5+ years) with direct government and insurance payments, ensuring recurring revenue.

Growth strategy and performance

• Serviced approximately 92,000 beds as of June 30, 2026, tripling since 2020.

• Growth driven by organic bed wins, new home construction, and accretive M&A in a fragmented market.

• Q2 2026 revenue was $93.6M with adjusted EBITDA of $8.0M and an 8.6% margin.

• Adjusted EBITDA margin and EBITDA per bed have steadily increased, reflecting operational efficiencies.

• Capital priorities include investing for growth, regular dividends, and opportunistic share repurchases.